TURKU, FI / ACCESS Newswire / June 5, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)(AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on developing novel ...

Detailed information about the transaction is given hereunder. Transaction notification under Article 19 of EU Market Abuse ...

Recent advance in single-cell RNA sequencing (scRNA-seq) has enabled large-scale transcriptional characterization of thousands of cells in multiple complex tissues, in which accurate cell type ...

Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company developing novel immunotherapies, has, as announced earlier today on 3 June 2025, approved the ...

Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First Tranche Bonds ...

TURKU, FI / ACCESS Newswire / June 2, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Favorable response rates and survival data in high/very high-risk frontline and r/r MDS support advancement ...

From sound to storage and control, these USB gadgets can seriously level up your PC gaming setup using the port you already ...

Tissue morphogenesis requires the precise control of cell shape and cell dynamics. Cell shape is governed by cell mechanics, which explains how a set of intracellular and extracellular forces ...